Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases

Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are chronic immune-mediated intestinal inflammatory disorders associated with microbial dysbiosis at multiple sites, particularly the gut. Anti-tumor necrosis factor-α (TNF-α) agents are important treatments for IBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yong Eun, Moon, Hye Su, Yong, Dongeun, Seo, Hochan, Yang, Jinho, Shin, Tae-Seop, Kim, Yoon-Keun, Kim, Jin Ran, Lee, Yoo Na, Kim, Young-Ho, Kim, Joo Sung, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012770/
https://www.ncbi.nlm.nih.gov/pubmed/35428806
http://dx.doi.org/10.1038/s41598-022-10450-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012770/
https://www.ncbi.nlm.nih.gov/pubmed/35428806
http://dx.doi.org/10.1038/s41598-022-10450-2

Ejemplares similares